Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state

Cardiovascular Research

Volumn 83, Issue 4, 2009, Pages 672-681

  Srisakuldee, Wattamon ^a,b   Jeyaraman, Maya M ^a,b   Nickel, Barbara E ^a   Tanguy, Stéphane ^a,b,c   Jiang, Zhi Sheng ^a,b,d   Kardami, Elissavet ^a,b  

^a St Boniface Research Centre   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF AVIGNON   (France)

^d UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Connexin43; Fibroblast growth factor 2; Phosphorylation; Post conditioning; Preconditioning; Protein kinase C

Indexed keywords

CONNEXIN 43; DIAZOXIDE; FIBROBLAST GROWTH FACTOR 2; LACTATE DEHYDROGENASE; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AMINO ACID SUBSTITUTION; ANIMALS; CONNEXIN 43; DIAZOXIDE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENETIC VECTORS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MUTAGENESIS, SITE-DIRECTED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 68949140963     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp142     Document Type: Article

References (40)

1. van Veen TA, van Rijen HV, Jongsma HJ. Physiology of cardiovascular gap junctions. Adv Cardiol 2006;42:18-40.
2. Severs NJ, Dupont E, Coppen SR, Halliday D, Inett E, Baylis D et al. Remodelling of gap junctions and connexin expression in heart disease. Biochim Biophys Acta 2004;1662:138-148.
3. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000;87:656-662.
4. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I et al. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. Faseb J 2003;17:1355-1357.
5. Nagy JI, Li WE, Roy C, Doble BW, Gilchrist JS, Kardami E et al. Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Exp Cell Res 1997;236:127- 136.
6. King TJ, Lampe PD. Temporal regulation of connexin phosphorylation in embryonic and adult tissues. Biochim Biophys Acta 2005;1719:24-35.
7. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK et al. Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 2007;12:267-277.
8. Padua RR, Merle PL, Doble BW, Yu CH, Zahradka P, Pierce GN et al. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J Mol Cell Cardiol 1998;30:2695-2709.
9. Padua RR, Sethi R, Dhalla NS, Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 1995;143:129-135.
10. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA et al. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 2007;42:222-233.
11. Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res 2004;62:154-166.
12. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J et al. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol 2002;282:H1071- H1080.
13. Doble BW, Dang X, Ping P, Fandrich RR, Nickel BE, Jin Y et al. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci 2004;117:507-514.
14. Doble BW, Ping P, Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 2000;86:293-301.
15. Srisakuldee W, Nickel BE, Fandrich RR, Jiang ZS, Kardami E. Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites. Cell Commun Adhes 2006;13:13-19.
16. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 2003;242:129-134.
17. Solan JL, Marquez-Rosado L, Sorgen PL, Thornton PJ, Gafken PR, Lampe PD. Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. J Cell Biol 2007;179:1301- 1309.
18. Dang X, Jeyaraman M, Kardami E. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol Cell Biochem 2006;289:201-207.
19. Doble BW, Ping P, Fandrich RR, Cattini PA, Kardami E. Protein kinase C-epsilon mediates phorbol ester-induced phosphorylation of connexin-43. Cell Commun Adhes 2001;8:253-256.
20. Kardami E, Banerji S, Doble BW, Dang X, Fandrich RR, Jin Y et al. PKC-dependent phosphorylation may regulate the ability of connexin43 to inhibit DNA synthesis. Cell Commun Adhes 2003;10:293-297.
21. Zhao J, Renner O, Wightman L, Sugden PH, Stewart L, Miller AD et al. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem 1998;273:23072-23079.
22. Miura T, Yano T, Naitoh K, Nishihara M, Miki T, Tanno M et al. Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43. Am J Physiol Heart Circ Physiol 2007;293:H1425-H1431.
23. Solan JL, Lampe PD. Key connexin 43 phosphorylation events regulate the gap junction life cycle. J Membr Biol 2007;217:35-41.
24. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 2008;295:H874-H882.
25. Jiang Z-S, Wen X-B, Tang Z-H, Srisakuldee W, Fandrich RR, Kardami E. High molecular weight FGF-2 promotes post-conditioning-like cardioprotection linked to the activation of protein kinase C, Akt and p70 S6 kinase. Can J Physiol Pharmacol 2009,in press.
26. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 2004;61:386-401.
27. Miura T, Ohnuma Y, Kuno A, Tanno M, Ichikawa Y, Nakamura Y et al. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2004;286:H214-H221.
28. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, Garcia-Dorado D et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005;97:583-586.
29. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005;67:234-244.
30. Budas GR, Churchill EN, Mochly-Rosen D. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol Res 2007;55:523-536.
31. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 2000;149:1503-1512.
32. Bao X, Lee SC, Reuss L, Altenberg GA. Change in permeant size selectivity by phosphorylation of connexin 43 gap-junctional hemichannels by PKC. Proc Natl Acad Sci USA 2007;104:4919-4924.
33. Axelsen LN, Stahlhut M, Mohammed S, Larsen BD, Nielsen MS, Holstein-Rathlou N-H et al. Identification of ischemia-regulated phosphorylation sites in connexin43: a possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J Mol Cell Cardiol 2006;40:790.
34. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996;79:647-658.
35. Bao X, Reuss L, Altenberg GA. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of serine 368. J Biol Chem 2004;279:20058-20066.
36. Li X, Heinzel FR, Boengler K, Schulz R, Heusch G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol 2004;36:161-163.
37. Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G. Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev 2007;12:261-266.
38. Schulz R, Heusch G. Connexin43 and ischemic preconditioning. Adv Cardiol 2006;42:213-227.
39. Shintani-Ishida K, Uemura K, Yoshida K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am J Physiol Heart Circ Physiol 2007;293:H1714- H1720.
40. Fenton RA, Dickson EW, Dobson JG Jr. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart. Life Sci 2005;77:3375-3388.